Understanding Antibiotics Misuse in Nigeria: A Detailed Study

By Staff Writer

October 17, 2023

Concerning Inappropriate Use of Antibiotics

In middle income countries such as Nigeria, the improper use of antibiotics poses a significant risk to the general population’s health. A recent investigation into consumers’ knowledge, perceptions, and the factors related with this usage was carried out in Ibadan, Nigeria. An alarmingly high percentage of consumers (95.9%) felt that antibiotics could prevent the growth of bacteria, and 60.7% believed that they could treat all infections using antibiotics. Unbelievably, 57.4% of respondents were not aware of antibiotic resistance, and just 14.7% of respondents possessed adequate information regarding antibiotics.

Factors That Influence the Improper Use of Antibiotics

The study revealed that 72.5% of customers have used antibiotics within the previous 12 months. Doctors prescribed antibiotics most often for Malaria, with amoxicillin being the most frequently used drug. Several factors significantly influenced the misuse of antibiotics. These included delayed test results, the belief that antibiotics offer instant relief, and the closeness of the pharmacy to a person’s home or workplace. 

Findings

This study reveals a crucial need for better public education about proper antibiotic use. Despite respondents having a high level of education, they still lack significant understanding of how to correctly use antibiotics and the risks of misuse. Social influences and antibiotic myths widen this knowledge gap. It’s not only false but also dangerous to believe that antibiotics can cure all diseases, stop diarrhea, or serve as a preventative measure after unprotected sex. These are all myths. Believing these misconceptions can lead to misuse or overuse of antibiotics. This behavior contributes to the global issue of antibiotic resistance.

This study revealed a concerning trend of consumers commonly self-medicating with antibiotics like amoxicillin, ampicillin, ciprofloxacin, tetracycline, and metronidazole. The low cost and easy over-the-counter availability of these antibiotics contribute to their overuse. We should avoid this practice because it increases the risk of antibiotic resistance. Another concern is the prescription of antibiotics for non-bacterial illnesses, such as uncomplicated malaria. Protozoa, not bacteria, cause malaria. While many antibiotics can treat malaria, their improper use could create resistant strains of the disease. 

Conclusion

The vast majority of customers lacked adequate understanding about the proper way to take antibiotics, which resulted in their inappropriate application of antibiotics. In order to increase understanding and encourage the correct application of antibiotics, specialised educational initiatives are required. There should be a stricter enforcement of the regulations that regulate the dispensing and marketing of antibiotics together with the provision of proper counseling.

Reference url

Recent Posts

Fabhalta C3 glomerulopathy treatment
       

Fabhalta C3 glomerulopathy treatment Gains EMA Endorsement as First Targeted Therapy

💡 Have you heard the latest on treatment options for rare kidney diseases?

Novartis’ Fabhalta (iptacopan) has received a positive opinion from the EMA, potentially paving the way for the first approved treatment for C3 glomerulopathy. This first-in-class therapy showed a remarkable 35.1% reduction in proteinuria, promising improved outcomes for patients facing this progressive condition.

Curious about the implications for healthcare and the economy? Dive into the full article to learn how Fabhalta could reshape the landscape for patients with C3G and other complement-mediated diseases.

#SyenzaNews #HealthcareInnovation #DrugDevelopment #MarketAccess

TLX250-CDx imaging agent
      

Zircaix: A Potential Breakthrough in Kidney Cancer Diagnosis

🔍 Could a new imaging agent revolutionize kidney cancer diagnosis?

The FDA’s acceptance of the Biologics License Application for TLX250-CDx marks a significant milestone in the fight against clear cell renal cell carcinoma (ccRCC). This investigational PET imaging tool promises non-invasive, high-accuracy diagnostics, which could lead to improved patient outcomes and better-targeted treatment plans.

Curious about its potential impact on healthcare and market dynamics? Dive into the full article to learn more!

#SyenzaNews #medicalimaging #oncology #HealthcareInnovation

personalized cancer vaccine
         

Personalized Cancer Vaccine in High-Risk Kidney Cancer Patients

🌟 Could personalized cancer vaccines be the future of cancer treatment?

A recent phase I clinical trial has shown promising results for a personalized cancer vaccine in patients with high-risk clear cell renal cell carcinoma (RCC). All participants developed immune responses, and notably, none experienced recurrence at a median follow-up of over 40 months! With a favorable safety profile, this approach may pave the way for more effective adjuvant therapies in oncology.

Jump into the full findings and see how this advancement could change the landscape of cancer treatment!

#SyenzaNews #oncology #biotechnology #innovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.